Filler Injections (filler + injection)

Distribution by Scientific Domains


Selected Abstracts


Allergic reaction to hydroxyethyl- methacrylate following intradermal filler injection

CONTACT DERMATITIS, Issue 6 2005
J. P. Thyssen
No abstract is available for this article. [source]


Hyaluronic acid filler injections with a 31-gauge insulin syringe

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Issue 1 2010
Adrian C Lim
ABSTRACT Hyaluronic acid gel is a commonly used skin/soft tissue filler in cosmetic dermatology. Hyaluronic acid fillers are packaged in proprietary luer-lock syringes that can be injected via a 30-gauge, 27-gauge or larger diameter needle depending on the consistency of the gel. A method of decanting proprietary hyaluronic acid fillers into multiple 31-gauge insulin syringes for injection is described. The use of a 31-gauge insulin syringe for filler injections can potentially enhance the injection process through more accurate product delivery and placement. This has the potential to produce a more balanced and symmetrical outcome for patients. Additional benefits include less injection pain, less bleeding/bruising and higher levels of patient satisfaction. [source]


The potpourri approach to hyaluronic acid filler injections

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Issue 1 2010
Adrian C Lim
ABSTRACT There is an ever-expanding range of hyaluronic acid fillers with varying physical characteristics available to cosmetic dermatologists. These fillers are commercially packaged in syringes of approximately 1 mL (range 0.5,2 mL) volume. Filler injectors are currently qualitatively and quantitatively restricted to fillers packaged in ready-to-go syringes. Patients often present for pan-facial rejuvenation requiring varying amounts of fillers as well as more than one type/subtype of filler for optimum correction. The potpourri approach allows access to a range of prepared hyaluronic acid filler subtypes that can be used on the same patient in the one session. The potpourri method centres on the use of multiple 31-gauge insulin syringes prepared with a range of different hyaluronic acid filler products that are ready for use. This increases flexibility with filler selection and has the potential to provide better filler-to-tissue match for patients. [source]